SPY334.57+0.24 0.07%
DIA274.62+0.72 0.26%
IXIC11,010.98-97.09 -0.87%

Ekso Bionics Holdings Q2 EPS $(1.88) May Not Compare To $(0.55) Estimate, Sales $2.30M Beat $1.62M Estimate

Ekso Bionics Holdings (NASDAQ:EKSO) reported quarterly losses of $(1.88) per share which missed the analyst consensus estimate of $(0.55) by 241.82 percent. This is a 6166.67 percent decrease over losses of $(0.03) per

Benzinga · -
Ekso Bionics Holdings (NASDAQ: EKSO) reported quarterly losses of $(1.88) per share which missed the analyst consensus estimate of $(0.55) by 241.82 percent. This is a 6166.67 percent decrease over losses of $(0.03) per share from the same period last year. The company reported quarterly sales of $2.30 million which beat the analyst consensus estimate of $1.62 million by 41.98 percent. This is a 29.49 percent decrease over sales of $3.26 million the same period last year.